CTD-O 12.5/40 Tablet
Marketer
Ipca Laboratories Ltd
Salt Composition
Olmesartan Medoxomil (40mg) + Chlorthalidone (12.5mg)
Overview CTD-O 12.5/40 Tablet
The dual-component CTD-O 12.5/40 Tablet effectively manages hypertension through a synergistic mechanism. Untreated hypertension significantly increases the risk of serious complications, including stroke, heart attack, and kidney failure. This medication can be administered with or without food, with dosage tailored to individual response and health status. Consistent daily dosing is crucial for optimal therapeutic effect; continue treatment as directed by your physician. Its diuretic component promotes increased urination; therefore, avoid nighttime administration within four hours of sleep. Regular use is vital, even during asymptomatic periods, as hypertension often presents subtly. Discontinuing treatment elevates the risk of cardiovascular events. Common side effects include dizziness, fatigue, nausea, diarrhea, headache, and hypotension. Increased urination is an expected diuretic effect, contributing to blood pressure control, not an adverse reaction. While less frequent, other side effects are possible. Consult the patient information leaflet and report persistent or bothersome side effects to your doctor; dosage adjustment or alternative therapies may be considered. Avoid use during pregnancy, and inform your physician of any pre-existing kidney, liver, cardiac, or diabetic conditions before initiating treatment. Alcohol consumption may potentiate hypotension and increase the likelihood of side effects.
Primary Ingredients of CTD-O 12.5/40 Tablet
The provided text is "undefined," therefore no rephrasing is possible.
Uses of CTD-O 12.5/40 Tablet
Elevated arterial blood pressure
Major Benefits of CTD-O 12.5/40 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the CTD-O 12.5/40 Tablet whole; avoid chewing, crushing, or breaking it. This medication can be administered with or without food, although consistent timing is recommended.
Common Side effects of CTD-O 12.5/40 Tablet:
- Nausea
- Taste change
- Diarrhea
- Upset stomach
- Weakness
- Headache
- Increased blood uric acid
- Dizziness
- Increased blood lipid level
- Electrolyte imbalance
- Decreased blood pressure
- Urinary tract infection
- Renal dysfunction
- Sore throat
- Abnormal liver function tests
- Increased potassium level in blood
How to use CTD-O 12.5/40 Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The CTD-O 12.5/40 Tablet can be consumed with or without food, though consistent timing is recommended.
How CTD-O 12.5/40 Tablet works:
Each CTD-O 12.5/40 Tablet contains a dual-drug formulation.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of CTD-O 12.5/40 tablets and alcohol can lead to significant sleepiness.
PregnancyCONSULT YOUR DOCTOR
Use of CTD-O 12.5/40 Tablet is contraindicated during pregnancy due to established fetal risk. In exceptional, life-threatening circumstances, a physician might prescribe it when the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingCONSULT YOUR DOCTOR
The use of CTD-O 12.5/40 Tablet while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Taking a CTD-O 12.5/40 Tablet might reduce attentiveness, impair vision, and cause drowsiness or dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Patients with severe renal impairment should exercise caution when using CTD-O 12.5/40 Tablet, as dose modification may be necessary. Physician consultation is advised; the medication is generally unsuitable for such individuals.
LiverCAUTION
Patients with hepatic impairment should use CTD-O 12.5/40 Tablet cautiously, potentially requiring dosage modification. Physician consultation is advised. CTD-O 12.5/40 Tablet is contraindicated in individuals with severe liver disease.
What if you forget to take CTD-O 12.5/40 Tablet :
Should you forget to take your CTD-O 12.5/40 Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Avoid taking a double dose.
Facts to Know About CTD-O 12.5/40 Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |






